Cocaine Effect Expectancies among Patients with Cocaine Use Disorder with and without Adult Attention Deficit Hyperactivity Disorder: Are There Any Relevant Differences?

References

• Abrams, D. B., and R. S. Niaura. 1987. Social learning theory. In Psychological theories of drinking and alcoholism, ed. H. T. Blane and K. E. Leonard, 131–78. New York: Guilford Press.
   Google Scholar
• Allen, M. S., D. Iliescu, and S. Greiff. 2022. Single item measure in psychological science. European Journal of Psychologist Assessment 38 (1):1–5. doi:10.1027/1015-5759/a000699.
   Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association.
   Google Scholar
• Arnsten, A. F. 2006. Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. The Journal of Clinical Psychiatry 67 (8):7–12.
   PubMed Web of Science ®Google Scholar
• Bandura, A. 1977. Social learning theory. Englewood Cliffs: Prentice-Hall.
   Google Scholar
• Barber, J. P., A. Frank, R. D. Weiss, J. Blaine, L. Siqueland, K. Moras, N. Calvo, J. Chittams, D. Mercer, and I. M. Salloum. 1996. Prevalence and correlates of personality disorder diagnoses among cocaine dependent outpatients. Journal of Personality Disorders 10:297–311. doi:10.1521/pedi.1996.10.4.297.
   Web of Science ®Google Scholar
• Beaulieu, J. M., T. D. Sotnikova, R. R. Gainetdinov, and M. G. Caron. 2006. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. Journal of Biological Chemistry 281:32072–80. doi:10.1074/jbc.M606062200.
   PubMed Web of Science ®Google Scholar
• Berridge, C. W., D. M. Devilbiss, M. E. Andrzejewski, A. F. Arnsten, A. E. Kelley, B. Schmeichel, C. Hamilton, and R. C. Spencer. 2006. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biological Psychiatry 60 (10):1111–20. doi:10.1016/j.biopsych.2006.04.022.
   PubMed Web of Science ®Google Scholar
• Butler, J., J. Rehm, and B. Fischer. 2017. Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses. Drug Alcohol & Dependence 180:401–16. doi:10.1016/j.drugalcdep.2017.08.036.
   PubMed Web of Science ®Google Scholar
• Carroll, K. M., and B. J. Rounsaville. 1993. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry 34:75–81. doi:10.1016/0010-440x(93)90050-e.
   PubMed Web of Science ®Google Scholar
• Castaneda, R., N. Sussman, R. Levy, and M. Trujillo. 1999. A treatment algorithm for attention deficit hyperactivity disorder in cocaine-dependent adults: A one-year private practice study with long-acting stimulants, fluoxetine and bupropion. Substance Abuse 20:55–67. doi:10.1080/08897079909511394.
   Google Scholar
• Casu, G., and P. Gremigni. 2019. Is a single-item measure of self-rated mental health useful from a clinimetric perspective? Psychotherapy and Psychosomatics 88:177–78. doi:10.1159/000497373.
   PubMed Web of Science ®Google Scholar
• Chen, R., D. D. Han, and H. H. Gu. 2005. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate. Journal of Neurochemistry 94:352–59. doi:10.1111/j.1471-4159.2005.03199.
   PubMed Web of Science ®Google Scholar
• Collins, S. L., F. R. Levin, R. W. Foltin, H. D. Kleber, and S. M. Evans. 2006. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol & Dependence 82:158–67. doi:10.1016/j.drugalcdep.2005.09.003.
   PubMed Web of Science ®Google Scholar
• Comín, M., S. Redondo, C. Daigre, L. Grau-López, M. Casas, and C. Roncero. 2016. Clinical differences between cocaine-dependent patients with and without antisocial personality disorder. Psychiatry Research 246:587–92. doi:10.1016/j.psychres.2016.10.083.
   PubMed Web of Science ®Google Scholar
• Davey, H. M., A. L. Barratt, P. N. Butow, and J. J. Deeks. 2007. A one-item question with a likert or visual analog scale adequately measured current anxiety. Journal of Clinical Epidemiology 60:356–60. doi:10.1016/j.jclinepi.2006.07.015.
   PubMed Web of Science ®Google Scholar
• Doyle, S. E., C. Ramôa, G. Garber, J. Newman, Z. Toor, and W. J. Lynch. 2014. A shift in the role of glutamatergic signaling in the nucleus accumbens core with the development of an addicted phenotype. Biological Psychiatry 76:810–15. doi:10.1016/j.biopsych.2014.02.005.
   PubMed Web of Science ®Google Scholar
• Epstein, J. E., D. E. Johnson, and C. K. Conners. 2001. The Conners’ Adult ADHD Diagnostic Interview for DSM-IV (CAADID): Technical manual. Toronto, ON.
   Google Scholar
• Epstein, J. N., and S. H. Kollins. 2006. Psychometric properties of an adult ADHD diagnostic interview. Journal of Attention Disorders 9:504–14. doi:10.1177/1087054705283575.
   PubMedGoogle Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2018. Recent changes in Europe´s cocaine market. http://www.emcdda.europa.eu/system/files/publications/10225/2018-cocaine-trendspotter-rapid-communication.pdf.
   Google Scholar
• Federici, M., E. C. Latagliata, A. Ledonne, F. R. Rizzo, M. Feligioni, D. Sulzer, M. Dunn, D. Sames, H. H. Gu, R. Nisticò, et al. 2014. Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate. Journal of Biological Chemistry 289:264–74. doi:10.1074/jbc.M113.495499.
   PubMed Web of Science ®Google Scholar
• Foltin, R. W., and M. W. Fischman. 1991. Assessment of abuse liability of stimulant drugs in humans: A methodological survey. Drug Alcohol & Dependence 28:3–48. doi:10.1016/0376-8716(91)90052-z.
   PubMed Web of Science ®Google Scholar
• Galen, L. W., and M. J. Henderson. 1999. Validation of cocaine and marijuana effect expectancies in treatment setting. Addictive Behaviours 24:719–24. doi:10.1016/s0306-4603(98)00110-5.
   PubMed Web of Science ®Google Scholar
• Gipson, C. D., and P. W. Kalivas. 2014. More cocaine—more glutamate—more addiction. Journal of Biological Chemistry 76:765–66. doi:10.1016/j.biopsych.2014.08.010.
   Google Scholar
• Gittelman, R., S. Mannuzza, R. Shenker, and N. Bonagura. 1985. Hyperactive boys almost grown up. 1. Psychiatric Status. Archives of General Psychiatry 42:937–47. doi:10.1001/archpsyc.1985.01790330017002.
   PubMed Web of Science ®Google Scholar
• Goldman, M. S., S. A. Brown, and B. A. Christiansen. 1987. Expectancy theory: Thinking about drinking. In Psychological theories of drinking and alcoholism, ed. H. T. Blane and K. E. Leonard, 181–220. New York: Guilford Press.
   Google Scholar
• Grella, C. E., V. Joshi, and Y. I. Hser. 2003. Followup of cocaine-dependent men and women with antisocial personality disorder. Journal of Substance Abuse Treatment 25:155–64. doi:10.1016/s0740-5472(03)00127-2.
   PubMed Web of Science ®Google Scholar
• Halperin, J. M., and K. P. Schulz. 2006. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder. Psychological Bulletin 132:560–81. doi:10.1037/0033-2909.132.4.560.
   PubMed Web of Science ®Google Scholar
• Hasin, D., S. Samet, E. Nunes, J. Meydan, K. Matseoane, and R. Waxman. 2006. Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. American Journal of Psychiatry 163:689–96. doi:10.1176/ajp.2006.163.4.689.
   PubMed Web of Science ®Google Scholar
• Herrero, M. J., A. Domingo-Salvany, M. Torrens, M. T. Brugal, F. Gutiérrez, and T. Itinere Investigators. 2008. Personality profile in young current regular users of cocaine. Substance Use & Misuse 43:1378–94. doi:10.1080/10826080801922652.
   PubMed Web of Science ®Google Scholar
• Jaffe, A. J., and M. M. Kilbey. 1994. The Cocaine Expectancy Questionnaire (CEQ): Its construction and predictive utility. Psychological Assessment 6:18–26. doi:10.1037/1040-3590.6.1.18.
   Google Scholar
• Jaffe, A. J., M. M. Kilbey, and G. R. Rosenbaum. 1989. Cocaine related expectancies: Their domain and implications for treatment. Pharmacology, Biochemistry & Behaviour 32:1094. doi:10.1016/0091-3057(89)90156-1.
   Google Scholar
• John, W. S., and L. T. Wu. 2017. Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015. Drug Alcohol & Dependence 180:376–84. doi:10.1016/j.drugalcdep.2017.08.031.
   PubMed Web of Science ®Google Scholar
• Kalivas, P. W., and N. D. Volkow. 2005. The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry 162:1403–13. doi:10.1176/appi.ajp.162.8.1403.
   PubMed Web of Science ®Google Scholar
• Kaye, S., J. A. Ramos-Quiroga, G. van de Glind, F.-R. Levin, S. V. Faraone, S. Allsop, L. Degenhardt, F. Moggi, C. Barta, M. Konstenius, et al. 2019. Persistence and subtype stability of ADHD among substance use disorder treatment seekers. Journal of Attention Disorders 23:1438–53. doi:10.1177/1087054716629217.
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J. 1985. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. American Journal of Psychiatry 142:1259–64. doi:10.1176/ajp.142.11.1259.
   PubMed Web of Science ®Google Scholar
• Kohut, S. J., T. Hiranita, S. K. Hong, A. L. Ebbs, V. Tronci, J. Green, L. Garcés-Ramírez, L. E. Chun, M. Mereu, A. H. Newman, et al. 2014. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine. Biological Psychiatry 76:802–09. doi:10.1016/j.biopsych.2014.03.031.
   PubMed Web of Science ®Google Scholar
• Kooij, S. J., S. Bejerot, A. Blackwell, H. Caci, M. Casas-Brugué, P. J. Carpentier, D. Edvinsson, J. Fayyad, K. Foeken, M. Fitzgerald, et al. 2010. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 10:67. doi:10.1186/1471-244X-10-67.
   PubMed Web of Science ®Google Scholar
• Krapacher, F. A., E. C. Mlewski, S. Ferreras, V. Pisano, M. Paolorossi, C. Hansen, and G. Paglini. 2010. Mice lacking p35 display hyperactivity and paradoxical response to psychostimulants. Journal of Neurochemistry 114:203–14. doi:10.1111/j.1471-4159.2010.06748.x.
   PubMed Web of Science ®Google Scholar
• Lambert, N. M., M. McLeod, and S. Schenk. 2006. Subjective responses to initial experience with cocaine: An exploration of the incentive-sensitization theory of drug abuse. Addiction 101:713–25. doi:10.1111/j.1360-0443.2006.01408.x.
   PubMed Web of Science ®Google Scholar
• Levin, F. R., S. M. Evans, and H. D. Kleber. 1998. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug & Alcohol Dependence 52 (1):15–25. doi:10.1016/s0376-8716(98)00049-0.
   PubMed Web of Science ®Google Scholar
• Lundahl, L. H., and S. E. Lukas. 2007. Negative cocaine effect expectancies are associated with subjective response to cocaine challenge in recreational cocaine users. Addiction Behaviours 32:1262–71. doi:10.1016/j.addbeh.2006.09.001.
   PubMed Web of Science ®Google Scholar
• Lynn, M. R. 1986. Determination and quantification of content validity. Nursing Research 35 (6):382–85. doi:10.1097/00006199-198611000-00017.
   PubMed Web of Science ®Google Scholar
• Mariani, J. J., J. Horey, A. Bisaga, E. Aharonovich, W. Raby, W. Y. Cheng, E. Nunes, and F. R. Levin. 2008. Antisocial behavioral syndromes in cocaine and cannabis dependence. American Journal of Drug and Alcohol Abuse 34:405–14. doi:10.1080/00952990802122473.
   PubMed Web of Science ®Google Scholar
• Mariani, J. J., E. J. Khantzian, and F. R. Levin. 2014. The self-medication hypothesis and psychostimulant treatment of cocaine dependence: An update. The American Journal on Addictions 23 (2):189–93. doi:10.1111/j.1521-0391.2013.12086.x.
   PubMed Web of Science ®Google Scholar
• Martínez-González, J. M., N. Albein-Urios, A. Verdejo-García, and O. Lozano-Rojas. 2014. Aspectos diferenciales del riesgo de abandono al inicio del tratamiento de la adicción a la cocaína en pacientes con trastornos de la personalidad [Differential aspects of treatment dropout risk in cocaine dependent patients with and without personality disorders]. Adicciones 26 (2):116–25.
   PubMedGoogle Scholar
• Martínez-Luna, N., C. Daigre, F. Palma-Álvarez, M. Perea-Ortueta, L. Grau-López, C. Roncero, E. Castell-Panisello, and J. A. Ramos-Quiroga. 2019. Psychiatric comorbidity and addiction severity differences in patients with ADHD seeking treatment for cannabis or cocaine use disorders. Journal of Attention Disorders 1–11. doi:10.1177/1087054719875787.
   Web of Science ®Google Scholar
• Mateo, Y., C. M. Lack, D. Morgan, D. C. Roberts, and S. R. Jones. 2005. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology 30:1455–63. doi:10.1038/sj.npp.1300687.
   PubMed Web of Science ®Google Scholar
• Matthies, S., and A. Philipsen. 2016. Comorbidity of personality disorders and adult attention deficit hyperactivity disorder (ADHD)—review of recent findings. Current Psychiatry Reports 18:33. doi:10.1007/s11920-016-0675-4.
   PubMed Web of Science ®Google Scholar
• Matuskey, D., Z. Bhagwagar, B. Planeta, B. Pittman, J. D. Gallezot, J. Chen, J. Wanyiri, S. Najafzadeh, J. Ropchan, P. Geha, et al. 2014. Reductions in brain 5-HT1B receptor availability in primarily cocaine-dependent humans. Biological Psychiatry 76:816–22. doi:10.1016/j.biopsych.2013.11.022.
   PubMed Web of Science ®Google Scholar
• Morgello, S., C. E. Holzer III, E. Ryan, C. Young, M. Naseer, S. A. Castellon, A. B. Frol, J. H. Atkinson, B. B. Gelman, I. Grant, et al. 2006. Interrater reliability of the psychiatric research interview for substance and mental disorders in an HIV-infected cohort: Experience of the National NeuroAIDS tissue consortium. International Journal of Methods in Psychiatric Research 15:131. doi:10.1002/mpr.189.
   PubMed Web of Science ®Google Scholar
• Napolitano, F., A. Bonito-Oliva, M. Federici, M. Carta, F. Errico, S. Magara, G. Martella, R. Nisticò, D. Centonze, A. Pisani, et al. 2010. Role of Aberrant Striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. Journal of Neuroscience 30:11043–56. doi:10.1523/JNEUROSCI.1682-10.2010.
   PubMed Web of Science ®Google Scholar
• Nunes, E. V., X. Liu, S. Samet, K. Matseoane, and D. Hasin. 2006. Independent versus substance-induced major depressive disorder in substance-dependent patients: Observational study of course during follow-up. Journal of Clinical Psychiatry 67:1561–67. doi:10.4088/jcp.v67n1010.
   PubMed Web of Science ®Google Scholar
• Polit, D. F., and C. T. Beck. 2006. The content validity index: Are you sure you know what’s being reported? Critique and recommendations. Research in Nursing & Health 29 (5):489–97. doi:10.1002/nur.20147.
   PubMed Web of Science ®Google Scholar
• Polit, D. F., and F. M. Yang. 2016. Measurement and measurement of change: A primer for health professinonals. Philadelphia, PA: Wolters Kluwer.
   Google Scholar
• Ramos-Quiroga, J. A., R. Bosch, V. Richarte, S. Valero, N. Gómez-Barros, M. Nogueira, G. Palomar, M. Corrales, N. Sáez-Francàs, M. Corominas, et al. 2012. Criterion and concurrent validity of conners adult ADHD diagnostic interview for DSM-IV (CAADID) Spanish version. Revista de Psiquiatría y Salud Mental 5:229–35. doi:10.1016/j.rpsm.2012.05.004.
   PubMed Web of Science ®Google Scholar
• Rohsenow, D. J., A. D. Sirota, R. A. Martin, and P. M. Monti. 2004. The cocaine effects questionnaire for patient populations: Development and psychometric properties. Addictive Behaviors 29:537–53. doi:10.1016/j.addbeh.2003.08.024.
   PubMed Web of Science ®Google Scholar
• Roncero, C., C. Daigre, C. Barral, E. Ros-Cucurull, L. Grau-López, L. Rodríguez-Cintas, S. Valero, M. Casas, and S. Valero. 2014. Neuroticism associated with cocaine-induced psychosis in cocaine-dependent patients: A cross-sectional observational study. PLoS One 9:e106111. doi:10.1371/journal.pone.0106111.
   PubMed Web of Science ®Google Scholar
• Ryan, S. A. 2019. Cocaine use in adolescents and young adults. Pedriatic Clinics of North America 66 (6):1135–47. doi:10.1016/j.pcl.2019.08.014.
   PubMed Web of Science ®Google Scholar
• Sargeant, M. N., M. A. Bornovalova, A. J. Trotman, S. Fishman, and C. W. Lejuez. 2012. Facets of impulsivity in the relationship between antisocial personality and abstinence. Addictive Behaviors 37 (3):293–98. doi:10.1016/j.addbeh.2011.11.012.
   PubMed Web of Science ®Google Scholar
• Schafer, J., and S. A. Brown. 1991. Marijuana and cocaine effect expectancies and drug use patterns. Journal of Consulting and Clinical Psychology 59:558–65. doi:10.1037/0022-006x.59.4.558.
   PubMed Web of Science ®Google Scholar
• Schafer, J., and W. Fals-Stewart. 1993. Effect expectancies for cocaine intoxication: Initial vs. descendent phases. Addictive Behaviours 18:171–77. doi:10.1016/0306-4603(93)90047-d.
   PubMed Web of Science ®Google Scholar
• Stacy, A. W., M. D. Newcomb, and P. M. Bentler. 1991. Expectancy in mediational models of cocaine use. Personality and Individual Differences 19:655–67. doi:10.1016/0191-8869(95)00100-K.
   Google Scholar
• Stahl, S. M. 2009. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder. The Journal of Clinical Psychiatry 71 (1):12–13. doi:10.4088/JCP.09bs05890pur.
   Web of Science ®Google Scholar
• Stahl, S. M. 2009. Norepinephrine and dopamine regulate signals and noise in the prefrontal cortex. The Journal of Clinical Psychiatry 70 (5):617–18. doi:10.4088/jcp.09bs05143.
   PubMed Web of Science ®Google Scholar
• Stahl, S. M. 2010. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder. The Journal of Clinical Psychiatry 71 (1):12–13. doi:10.4088/JCP.09bs05890pur.
   PubMed Web of Science ®Google Scholar
• Storebø, O. J., and E. Simonsen. 2016. The association between ADHD and antisocial personality disorder (ASPD): A review. Journal of Attention Disorders 20:815–24. doi:10.1177/1087054713512150.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). Key substance use and mental health indicators in the United States: results from the 2018 National survey on drug use and health. https://store.samhsa.gov/system/files/pep19-5068.pdf.
   Google Scholar
• Torrens, M., D. Serrano, M. Astals, G. Pérez-Domínguez, and R. Martín-Santos. 2004. Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV. American Journal of Psychiatry 161:1231–37. doi:10.1176/appi.ajp.161.7.1231.
   PubMed Web of Science ®Google Scholar
• Trujols, J., M. J. Portella, I. Iraurgi, M. J. Campins, N. Siñol, and J. P. de Los Cobos. 2013. Patient-reported outcome measures: Are they patient-generated, patient-centred or patient-valued? Journal of Mental Health (Abingdon, England) 22 (6):555–62. doi:10.3109/09638237.2012.734653.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime (UNODC). (2019). World drug report. https://wdr.unodc.org/wdr2019/index.html.
   Google Scholar
• Van Emmerik-van Oortmerssen, K., G. van de Glind, M. W. Koeter, S. Allsop, M. Auriacombe, C. Barta, R. A. Schoevers, Y. Burren, P.-J. Carpentier, and S. Carruthers. 2014. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: Results of the IASP study. Addiction 109:262–72. doi:10.1111/add.12370.
   PubMed Web of Science ®Google Scholar
• Van Rijsbergen, G. D., C. L. Bockting, M. Berking, M. W. Koeter, and A. H. Schene. 2012. Can a one-item mood scale do the trick? Predicting relapse over 5.5-years in recurrent depression. PLoS One 7 (10):e46796. doi:10.1371/journal.pone.0046796.
   PubMed Web of Science ®Google Scholar
• Vergara-Moragues, E., F. González-Saiz, O. Lozano Rojas, I. Bilbao Acedos, F. Fernández Calderon, P. Betanzos Espinosa, A. Verdejo García, and M. Pérez García. 2011. Diagnosing adult attention deficit/hyperactivity disorders in patients with cocaine dependence: Discriminant validity of Barkley executive dysfunction symptoms. European Addiction Research 17:279–84. doi:10.1159/000329725.
   PubMed Web of Science ®Google Scholar
• Vergara-Moragues, E., A. Verdejo-García, O. M. Lozano, S. Santiago-Ramajo, F. González-Saiz, P. Betanzos Espinosa, and M. Pérez García. 2017. Association between executive function and outcome measure of treatment in therapeutic community among cocaine dependent individuals. Journal of Substance Abuse Treatment 78:48–55. doi:10.1016/j.jsat.2017.04.014.
   PubMed Web of Science ®Google Scholar
• Verheul, R., W. van den Brink, and C. Hartgers. 1995. Prevalence of personality disorders among alcoholics and drug addicts: An overview. European Addiction Research 1:166–77. doi:10.1159/000259080.
   Google Scholar
• Volkow, N. D., J. M. Swanson, and C. G. Solomon. 2013. Adult attention deficit–hyperactivity disorder. New England Journal of Medicine 369:1935–44. doi:10.1056/NEJMcp1212625.
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., G. J. Wang, M. W. Fischman, R. W. Foltin, J. S. Fowler, N. N. Abumrad, S. Vitkun, J. Logan, S. J. Gatley, N. Pappas, et al. 1997a. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827–30. doi:10.1038/386827a0.
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., G. J. Wang, J. S. Fowler, J. Logan, S. J. Gatley, R. Hitzemann, A. D. Chen, N. Pappas, and N. Pappas. 1997b. Decreased striatal responsivity in detoxified cocaine-dependent individuals. Nature 386:830–33. doi:10.1038/386830a0.
   PubMed Web of Science ®Google Scholar
• Weiss, R. D., and S. M. Mirin. 1986. Subtypes of cocaine abusers. Psychiatric Clinics of North America 9:491–501. doi:10.1016/S0193-953X(18)30608-7.
   PubMed Web of Science ®Google Scholar
• Weiss, R. D., H. G. Pope, and S. M. Mirin. 1985. Treatment of cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline. Drug Alcohol & Dependence 15:69–72. doi:10.1016/0376-8716(85)90031-6.
   PubMed Web of Science ®Google Scholar
• Wiers, R. W., K. Houben, and J. Kraker. 2007. Implicit cocaine associations in active cocaine users and controls. Addictive Behaviors 32:1284–89. doi:10.1016/j.addbeh.2006.07.009.
   PubMed Web of Science ®Google Scholar
• Wilens, T. E. 2008. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology 28 (3 Suppl 2):S46–S53. doi:10.1097/JCP.0b013e318173312f.
   PubMed Web of Science ®Google Scholar
• World Medical Association. 2013. Declaration of Helsinki – Ethical principles for medical research involving human individuals 310(20):2191–2194 . Fortaleza, WMA: JAMA: doi:10.1001/jama.2013.281053 .
   Google Scholar